Caplin Point is a fast growing, fully integrated Pharmaceutical company with a dominant presence in Latin America, Francophone Africa and a growing presence in the Regulated markets such as USA and EU. The company was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994…
Read MoreBusiness commenced | 2018 |
Revenue contribution | 8% (FY20) |
Products offered | Injectable & Ophthalmic |
ANDAs Filed | 20 |
ANDAs Approved | 16 |
ANDAs Pipeline | 45 |
India | |
---|---|
% of total export | 60% |
Outsourced within India | 20% |
Manufactured inhouse | 40% |
China | |
% of total export | 40% |
Partners | 8 |
Revenue contribution | 92% (FY20) |
Products offered | Majority products under WHO essential list |
Product registrations | 4000+ |
Products in pipeline | 900+ |
Therapies covered | 36 |
Therapies in pipeline | Psychiatric, Neuropsychiatric & Oncology |
A first generation entrepreneur, C.C.Paarthipan’s stint in the Pharmaceutical industry goes back almost 3 decades...Read More >>
Dr. Sridhar Ganesan has over 35 years of varied global leadership experience..Read More >>
Mr D Sathyanarayanan has over 30 years of experience in the application..Read More >>
Dr C K Gariyali, aged 72, is a retired IAS officer and holds a Doctorate in Women Studies and she has been Principal..Read More >>
Dr R Nagendran has a Ph. D in Ecology & Ethology and M. SC in Zoology..Read More >>
Mr S Deenadayalan is a Post Graduate degree in Social Work from Madras School of Social Work and Under Graduate degree..Read More >>
Chennai, Aug 27 (UNI) The Hindustan Chamber of Commerce (HCC) today celebrated its Chamber…
Read More »Happy to announce that Caplin Point Laboratories is listed on “Forbes Asia’s 200 Best…
Read More »Chennai, Sep 24, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Amaris…
Read More »Chennai, September 08, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin…
Read More »Chennai, August 17, 2021: Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories Ltd,…
Read More »Chennai, July 14, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin…
Read More »Chennai, April 23, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin…
Read More »Chennai, April 22, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin…
Read More »Chennai, April 19, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin…
Read More »as #36 India Companies Ranked by Value as #760 Global Companies Ranked by Value…
Read More »
Caplin Point aims to create new niches in our existing markets to ensure the current foothold remains strong and innovative. We envisage implementing our unique business model across the globe to ensure access to quality medicines at affordable prices.
Innovate to change the rules of the game and not to compete in the game. Innovation distinguishes between a leader and a follower.
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 following its Initial Public Offering (IPO) which was oversubscribed 117 times, the proceeds of which were deployed in setting up a manufacturing facility at Pondicherry. Thereafter, the Company expanded its product range and increased its production capacity...
+91 44 2496 8000
Caplin Point Laboratories Ltd. 3rd Floor, Ashvich Towers, No 3, Developed Plots Industrial Estate, Perungudi, Chennai 600096. Tamil Nadu, India.